NLRP3 and Insulin resistance: Current evidence indicates the participation of the nucleotide-binding oligomerization domain-like receptor family (NOD-like) pyrin domain containing 3 (NLRP3) inflammasome in the development of inflammation and insulin resistance in diverse tissues [3,4,5,6,7], which are early stages in the pathogenesis of T2D.